Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BIAF save search
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
Published: 2023-01-24 (Crawled : 15:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 20.13%
H: 108.9%
C: 46.07%
research respiratory trial results publication
PRIME AE Enhances Midwest Presence with Jacobi, Toombs … – PR Newswire
Published: 2023-09-20 (Crawled : 22:00) - spacfeed.com
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
ICCT | $1.18 -6.35% -6.78% 34K
|
Professional, Scientific, and T...
|
| O: -6.11%
H: 21.95%
C: 10.03%
prime
AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF … – PR Newswire
Published: 2023-09-20 (Crawled : 22:00) - spacfeed.com
BGC | $7.515 -0.73% -0.73% 2.7M
|
n/a
|
| O: -2.07%
H: 3.37%
C: 1.73%
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -9.09%
H: 2.14%
C: -24.29%
ICCT | $1.18 -6.35% -6.78% 34K
|
Professional, Scientific, and T...
|
| O: -6.11%
H: 21.95%
C: 10.03%
network
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 1.05%
H: 14.52%
C: 6.22%
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
Published: 2023-05-01 (Crawled : 13:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -0.51%
H: 7.22%
C: 5.67%
financial
bioAffinity Technologies Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -5.37%
H: 5.67%
C: 3.96%
financial results
bioAffinity Technologies Presents Research Findings at CYTO 2023
Published: 2023-05-22 (Crawled : 14:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 0.0%
H: 3.83%
C: 3.83%
research
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 00:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -2.33%
H: 7.14%
C: 2.93%
business update financial results
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 1.26%
H: 2.05%
C: 1.32%
research meeting cancer
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 2.97%
H: 1.92%
C: 0.48%
year financial results
WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit
Published: 2022-09-01 (Crawled : 17:00) - prnewswire.com
BIAF | $2.9 2.47% 2.41% 210K
|
| Email alert
Add to watchlist
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 13:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -2.83%
H: 1.82%
C: 0.0%
financial update results
bioAffinity Technologies Announces Pricing of IPO
Published: 2022-09-01 (Crawled : 12:20) - feed.businesswire.com
BIAF | $2.9 2.47% 2.41% 210K
|
| Email alert
Add to watchlist
technology
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 0.0%
H: 2.68%
C: -0.36%
lung conference flow results
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board
Published: 2024-02-06 (Crawled : 13:30) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -0.38%
H: 0.64%
C: -0.64%
lung network medical
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
Published: 2022-11-08 (Crawled : 13:20) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: -0.18%
H: 5.22%
C: -0.96%
report financial results
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
Published: 2023-04-25 (Crawled : 13:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 2.44%
H: 0.0%
C: -2.38%
lung symposium cancer
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
Published: 2023-11-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 0.6%
H: 0.0%
C: -2.39%
lung cancer
bioAffinity Technologies In The News - January 30, 2024
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 2.5%
H: 0.51%
C: -2.44%
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer - January 23, 2024
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
BIAF | $2.9 2.47% 2.41% 210K
|
|
| O: 5.3%
H: 0.0%
C: -2.52%
award patent cancer treatment
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.